Postdoctoral fellow studying Maintenance of Mammalian Genome Stability

We are seeking an enthusiastic, driven postdoctoral fellow to join our dynamic cell biology research group. Our research interests focus on the cellular responses to DNA damage and seeks to leverage this knowledge to improve therapeutics, especially radiotherapy and to gain insight into the etiology of cancer development.

The ideal candidate will have extensive experience in cellular models of cancer and a deep knowledge in one or more areas of epigenetics, DNA damage responses and cell cycle control. Major assets would include experience in CRISPR/Cas9, high content imaging and analysis and/or assays for higher-order chromatin structures.

We are an intensive academic laboratory that is well funded through multiple national and international agencies. The Harding lab (https://medbio.utoronto.ca/faculty/harding) formed in 2018 and is embedded within a diverse research-intensive environment (https://www.uhnresearch.ca/institutes/pm) that is part of Canada’s largest academic research hospital network. Located in Toronto’s discovery district we offer the most vibrant academic community in Canada with subject matter experts in anything you can imagine all in walking distance. Competitive salaries are mandated by our institution and start at $55000. In this collaborative environment access to the PI is effortless, salaries are guaranteed with support for fellowship applications and international meeting attendance.

Qualifications and Experience

• PhD in biological sciences obtained within last 3 years PhD
• Students nearing graduations are encouraged to apply
• Background in cellular biology, especially DNA damage and cell cycle signalling
• Publication record in reputable journals
• Experience with standard cell and molecular biology methods including cell culture, transfection/transduction, western blotting, qPCR, fluorescent microscopy, cloning and CRISPR/Cas9
• Experience in high content screening, assays of chromatin conformation and/or intermediate comfort with next generation sequencing analysis (RNA-seq, ChIP-seq etc.) are major assets

Please include a statement of interest and qualifications alongside a curriculum vitae. Only those individuals selected for an interview will be contacted. Reference requests will follow, please do not send at this time.